SBMU Journals
  • New Submission
  • Register
  • Login
  • English
    • 简体中文

Archives of Academic Emergency Medicine

  • Home
  • About
    • Policies
    • Editorial Team
    • Reviewer guideline
    • Statistics
    • Contact
  • Issues
    • Current
    • Archives
  • Announcements
  • Indexing/Abstracting
  • For authors
    • New Submission
    • Author guidelines
    • Article withdrawal
    • Peer review process
    • FAQ
  • Ethics
    • Ethical requirements
    • Plagiarism Policy
    • Authorship conflicts
    • Malpractice statements
    • Copyright Notice
    • Intellectual properties
    • Privacy Statement
    • Artificial intelligence & Authorship
    • Retraction Cosiderations
Advanced Search
  1. Home
  2. Archives
  3. Vol. 9 No. 1 (2021): Continuous volume
  4. Case Report

Vol. 9 No. 1 (2021)

January 2021

Rare and Underestimated Association of Pulmonary Embolism and Olanzapine Therapy; Report of Two Cases Pulmonary Embolism and Olanzapine Therapy

  • Hammam Rasras
  • Mustapha Beghi
  • Maryem Samti
  • Nabila Ismaili
  • Noha El Ouafi

Archives of Academic Emergency Medicine, Vol. 9 No. 1 (2021), 1 January 2021 , Page e17
https://doi.org/10.22037/aaem.v9i1.1063 Published: 2021-02-05

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Abstract:

Venous thromboembolic disease (VTD) is a very common and severe pathological condition in which there are many predisposing factors. Olanzapine is a drug frequently used in psychiatric practises; it is thought to increase the risk of VTD. Here, we report two cases, a young man and a woman, with a medical history of schizophrenia treated by olanzapine who developed pulmonary embolism and we did not find any aetiologies of VTD in them. Due to the link between olanzapine and pulmonary embolism, which has been previously described, olanzapine is considered responsible for this problem. Two mechanisms have been reported in the literature in this regard; significant weight gain and lethargy, which are very common side effects of olanzapine. So far, no direct effect of olanzapine on platelet aggregation or coagulation has been found. In patients developing VTD while being treated with olanzapine, discontinuation of olanzapine as a treatment option must be done with an adjustment of antipsychotic treatment and regular monitoring of psychic symptoms. Since the diagnosis of pulmonary embolism is not easy to make in a schizophrenic patient, clinicians should take that in consideration when prescribing these drugs and when facing clinical situations where VTD is suspected.

Keywords:
  • Pulmonary embolism
  • venous thromboembolism
  • risk factors
  • antipsychotic agents
  • olanzapine
  • pdf

How to Cite

1.
Rasras H, Beghi M, Samti M, Ismaili N, El Ouafi N. Rare and Underestimated Association of Pulmonary Embolism and Olanzapine Therapy; Report of Two Cases: Pulmonary Embolism and Olanzapine Therapy. Arch Acad Emerg Med [Internet]. 2021 Feb. 5 [cited 2025 May 22];9(1):e17. Available from: https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/1063
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Kannan R, Molina DK. Olanzapine: a new risk factor for pulmonary embolus? The American journal of forensic medicine and pathology. 2008;29(4):368-70.

Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood reviews. 2009;23(5):225-9.

Dijkstra M, van der Weiden C, Schol-Gelok S, Muller-Hansma A, Cohen G, van den Bemt P, et al. Venous thrombosis during olanzapine treatment: a complex association. The Netherlands journal of medicine. 2018;76(6):263-8.

Grahmann H. Thombose hazard in chlorpromazine and reserpine therapy of endogenous psychosis. Nervenarzt. 1959;30:224-5.

Hägg S, Spigset O. Antipsychotic-induced venous thromboembolism. CNS drugs. 2002;16(11):765-76.

Hägg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. Drug safety. 2008;31(8):685-94.

Almuqdadi A, Bulatova N, Yousef A-M. The effect of atypical antipsychotics on platelet aggregation. Open Journal of Hematology. 2016;7(1).

Carrizo E, Fernández V, Quintero J, Connell L, Rodríguez Z, Mosquera M, et al. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophrenia research. 2008;103(1-3):83-93.

Nederland Z. FarmacotherapeutischKompas [Available from: https://www.farmacotherapeutischkompas.nl/.

Dutch SmPC olanzapine Zalasta 2.5/5/7.5/10/15/20 tablets 2012 [26 July 2012:[Available from: https://www.ema.europa.eu/en/documents/product-information/zalasta-epar-product-information_nl.pdf.

  • Abstract Viewed: 950 times
  • pdf Downloaded: 322 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Make a Submission

Make a Submission

SJR

SCImago Journal & Country Rank

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

This journal is distributed under the terms of CC BY-NC 3.0. Design and publishing by SBMU journals. All credits and honors to PKP for their OJS. 

 Sitemap | ISSN-ONLINE: 2645-4904

Support Contact: ma.saghaei63@gmail.com

With the goal of net zero carbon emissions, this journal is published only in electronic format.

Powered by OJSPlus